Financhill
Sell
37

CLRB Quote, Financials, Valuation and Earnings

Last price:
$3.75
Seasonality move :
-8.15%
Day range:
$3.66 - $3.83
52-week range:
$2.71 - $42.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
137.94x
P/B ratio:
0.91x
Volume:
7.5K
Avg. volume:
221.8K
1-year change:
-90.76%
Market cap:
$6.8M
Revenue:
--
EPS (TTM):
-$6.47

Earnings Data

Next earnings date for CLRB
Mar 12
2026
Most recent earnings per share
-$1.41
Beat by $1.12
(Nov 13/2025)
Consensus Estimate
-$2.53
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CLRB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/12/2026 Q4 -- -- -- -$1.22 --
11/13/2025 Q3 -- -- -$1.41 -$2.53 $1.12
08/14/2025 Q2 -- -- -$3.39 -$3.70 $0.31
05/13/2025 Q1 -- -- -$0.14 -$4.90 $4.76
03/13/2025 Q4 -- -- -$1.53 -$10.58 $9.04
11/18/2024 Q3 -- -- -$0.37 -$11.20 $10.83
08/13/2024 Q2 -- -- -$0.18 -$8.10 $7.92
05/14/2024 Q1 -- -- -$0.91 -$16.90 $15.99
03/27/2024 Q4 -- -- -$0.41 -$15.90 $15.49
11/02/2023 Q3 -- -- -$46.48 -$13.35 -$33.13
08/04/2023 Q2 -- -- -$27.12 -$19.95 -$7.17
05/10/2023 Q1 -- -- -$19.16 -- --
03/21/2023 Q4 -- -- -$40.00 -- --
11/08/2022 Q3 -- -- -$1.28 -- --
08/05/2022 Q2 -- -- -$12.17 -- --
05/10/2022 Q1 -- -- -$1.00 -- --
03/02/2022 Q4 -- -- -$0.97 -- --
11/08/2021 Q3 -- -- -$0.97 -- --
08/09/2021 Q2 -- -- -$1.14 -- --
05/10/2021 Q1 -- -- -$1.32 -- --
03/02/2021 Q4 -- -- -$0.80 -- --
11/09/2020 Q3 -- -- -$1.49 -- --
08/10/2020 Q2 -- -- -$2.62 -- --
03/31/2020 Q1 -- -- -$4.21 -- --
12/31/2019 Q4 -- -- -$3.60 -- --
09/30/2019 Q3 -- -- -$4.16 -- --
06/30/2019 Q2 -- -- -$4.58 -- --
03/31/2019 Q1 -- -- -$7.59 -- --
12/31/2018 Q4 -- -- -$8.09 -- --
09/30/2018 Q3 -- -- -$16.51 -- --
08/14/2018 Q2 -- -- -$16.90 -- --
03/31/2018 Q1 -- -- -$21.00 -- --
12/31/2017 Q4 -- -- -$34.00 -- --
09/30/2017 Q3 -- -- -$26.00 -- --
06/30/2017 Q2 -- -- -$696.00 -- --
03/31/2017 Q1 -- -- -$24.07 -- --
03/15/2017 Q4 -- -- -$24.93 -- --
11/11/2016 Q3 -- -- -$43.00 -- --
08/15/2016 Q2 -- -- -$49.00 -- --
05/12/2016 Q1 -- -- $91.00 -- --
03/10/2016 Q4 -- -- $110.81 -- --

Cellectar Biosciences, Inc. Earnings Questions

  • How Much did Cellectar Biosciences, Inc. Generate in Revenue Last Quarter?

    Cellectar Biosciences, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Cellectar Biosciences, Inc. Beat Earnings Last Quarter?

    Cellectar Biosciences, Inc. announced earnings per share of -$1.41 which represents a beat of analyst forecast a -$2.53 per share.

  • Is Cellectar Biosciences, Inc. Profitable?

    Cellectar Biosciences, Inc. reported -$52.3K that represents -$0.02 per share over the last quarter.

  • What is the Analyst Consensus for Cellectar Biosciences, Inc. EPS Next Year?

    Cellectar Biosciences, Inc.'s earnings are forecast to decrease from -$41.89 per share to -$47.03 per share next year representing a decrease of -78.71%.

  • When is Cellectar Biosciences, Inc.'s Earnings Date?

    Cellectar Biosciences, Inc.'s next earnings date is March 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock